Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Sponsored by Brigham and Women's Hospital
About this study
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. In addition, we also examine blood and urine biomarkers (proteins).
Where this study is enrolling
- I'm interested
UT Southwestern Medical Center
Dallas, Texas
Who can participate
Inclusion criteria
- ✓Undergoing heart surgery
- ✓Willing to provide consent
Exclusion criteria
- ✕Enrolled in a concurrent drug or device trial that precludes concurrent enrollment
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.